News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
Biotech/Pharma - Alliances
Parnell Pharmaceuticals Holdings Acquires License For Intellectual Property And Rights To Develop Compounds For Bone And Dermal Regeneration 7/25/2014
Lion Biotechnologies, Inc. Announces Exclusive License Agreement With H. Lee Moffitt Cancer Center & Research Institute 7/25/2014
MYOS (MYOS) Extends Manufacturing And Supply Agreement For Fortetropin 7/25/2014
Pfizer Inc. (PFE) Backs Out of Funding Puma Biotechnology (PBYI) Cancer Drug Trials 7/24/2014
Cubist Pharmaceuticals, Inc. (CBST) Strikes Agreement With Competitor To Delay Generic Cubicin 7/24/2014
Taconic Announces New Agreement To Distribute Next Generation NOG Mouse Models 7/24/2014
Gilead Sciences, Inc. (GILD), Medicines Patent Pool Strike Deal: New Opportunity For Indian Drugmakers 7/24/2014
Immune Pharmaceuticals, Inc. Release: Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 7/24/2014
TransCelerate BioPharma Selects Cognizant (CTSH) To Develop A Clinical Trials Collaboration Platform 7/24/2014
Cipher Pharmaceuticals (DND.TO) And Ranbaxy Laboratories (RANBAXY.BO) Announce Distribution Agreement For Isotretinoin Product In Brazil 7/24/2014
Bristol-Myers Squibb Company (BMY) And Ono Pharmaceutical Company, Ltd. Announce Strategic Immuno-Oncology Collaboration In Japan, South Korea And Taiwan 7/24/2014
Evogene Ltd. (EVGN) Announces Amendment To Bayer Wheat Agreement To Focus On Discovery Of Novel Genomic Promoters 7/24/2014
LSI Medience Corporation And Kineticos Sign Agreement Related To The Presepsin Biomarker In Sepsis Management And Treatment 7/24/2014
Agilent Technologies Inc. (A) Signs Co-Marketing Agreement With MRM Proteomics To Advance Quantitative Proteomics Solutions 7/24/2014
ArmaGen Technologies, Inc. Licenses AGT-182 Rights To Shire For Up To $225M 7/23/2014
MorphoSys AG And Galapagos NV (GLPG.BR) Advance Joint Antibody Program In Inflammatory Diseases Into Preclinical Development 7/23/2014
Sirona Biochem Announces Shares For Services Agreement 7/23/2014
China Cord Blood Corporation And Cordlife Group Limited Announce Collaboration To Aid Asia-Based Patients With Cord Blood Stem Cell Therapy 7/23/2014
Lion Biotechnologies, Inc. Leases New Research Laboratory 7/23/2014
AmorChem l.p. Invests In A Novel Drug For Atherosclerosis. 7/23/2014
Anacor Pharmaceuticals, Inc. (ANAC) Inks Exclusive Deal With Sandoz, Inc. For Kerydin; Anacor To Receive Upfront $40 Million 7/22/2014
Assay Depot, Inc. Partners With Kansas City Area Life Science Institute To Create World’s First Academic Research Exchange 7/22/2014
Advaxis, Inc. And MedImmune (AZN) Partner On Immuno-Oncology Combination Clinical Trial 7/22/2014
Neurotrope Enters Collaborative Agreement With Icahn School Of Medicine At Mount Sinai For Use Of Bryostatin-1 In The Treatment Of Niemann-Pick Disease Type C 7/22/2014
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014
ICON And University of Cambridge Collaborate To Deliver Educational Programme On Pricing & Market Access Strategy 7/22/2014
Arch Therapeutics Announces Collaboration With University College Cork School Of Pharmacy 7/22/2014
Coté Orphan Consulting And The ERA Consulting Group Announce A Strategic Alliance 7/22/2014
MonoSol Rx Enters Into Exclusive Licensing Agreement With Galena Biopharma  (GALE) For Zuplenz(R) Oral Soluble Film 7/22/2014
Pressure BioSciences, Inc. (BBII) To Develop Front-End Sample Preparation For Parabase Genomics' Targeted Next Generation Sequencing Testing Platform 7/22/2014
Envy Medical And Libbs Farmaceutica Announce Strategic Marketing, Sales And Distribution Agreement For Brazil 7/22/2014
DataDirect Networks Joins Global Alliance for Genomics And Health 7/22/2014
MediGene AG (MDGEF.PK): Trianta Announces Extension Of Research Funding In The Transregional Collaborative Research Centre Of The German Research Foundation (DFG) For Adoptive T Cell Therapy 7/22/2014
Galena Biopharma  (GALE) Enters Into Definitive Agreement to License U.S. Rights for Zuplenz® (ondansetron) Oral Soluble Film 7/22/2014
SANUWAVE Health Signs Strategic Agreement With Premier Shockwave To Manage OssaTron Devices 7/22/2014
Arena Pharmaceuticals, Inc. (ARNA) Enters Into Marketing And Supply Agreement For BELVIQ® (Lorcaserin Hcl) In Israel 7/21/2014
Celladon Corporation Announces In-License Of Stem Cell Factor Development Program 7/21/2014
Basilea Pharmaceutica (BSLN.SW) To Launch Zevtera®/Mabelio®) (ceftobiprole medocaril) In Europe Through A Commercial Services Provider 7/21/2014
EirGenix And Formosa Laboratories Collaborate To Establish A Platform For ADC CMC Integration Services 7/18/2014
Sanofi (France) (SAN.PA) Digs Into Academia, Joins Massachusetts Institute of Technology (MIT) Forum's Manufacturing Advisory Board 7/18/2014
Post Torrent Pharmaceuticals Ltd. Sell Off, Elder Pharmaceutical Ltd. Hopes To Do A Shelcal With Eldervit, Lays Out Product Extensions To Make It A Rs 100 Crore Brand 7/18/2014
Lannett Company, Inc. (LCI) Signs Agreement To Be Exclusive U.S. Distributor Of Authorized Generic Of Hypertension Drug, ACEON® 7/18/2014
Helsinn Group And Marketing Enter Into Agreement For Marketing Rights Of Netupitant-Palonosetron Fixed-Dose Combination (NEPA) In The UK And Ireland And For Palonosetron Monotherapy In The UK 7/17/2014
BioLife Solutions, Inc. (BLFS.OB) Announces Manufacturing Agreement With Somahlution LLC 7/17/2014
CryoPort, Inc. And DHL Partner To Provide Cryogenic Logistics Solutions For Life Sciences And Healthcare Clients 7/17/2014
MYOS (MYOS) Announces Agreement With Cloud Pharmaceuticals, Inc. To Develop Small Molecules Targeting Sarcopenia And Cachexia 7/17/2014
The Medicines Patent Pool Signs A Record Seven New Sub-Licences To Speed The Availability Of Generic HIV Medicines To Developing Countries 7/17/2014
Juvenile Diabetes Research Foundation Partner ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Announces Key Project Milestone To Advance Innovative Encapsulated Cell Replacement Therapy Product For Type 1 Diabetes 7/17/2014
Eli Lilly and Company (LLY) Inks $45 Million Immunotherapy Development Deal With Immunocore Limited 7/16/2014
Isis Pharmaceuticals, Inc. (ISIS) Earns $1 Million From GlaxoSmithKline (GSK) For Advancing ISIS-TTR Rx 7/16/2014
Cara Therapeutics, Inc. (CARA) Earns Milestone Payment From Maruishi Pharmaceutical For Completion Of Phase 1 Clinical Trial Of I.V. CR845 In Japan 7/16/2014
Tauriga Sciences Inc. (TAUG) Signs License Agreement With Targeted Medical Pharma 7/16/2014
RAN Biotechnologies Announces Distributorship Agreement With Fluigent 7/15/2014
Novartis AG (NVS), Google Inc. Strike Smart Contact Lenses Pact 7/15/2014
Novartis AG (NVS) To Test Alzheimer's Drugs In Patients Without Symptoms 7/15/2014
GlaxoSmithKline (GSK) Invests Up To $25 Million In Codexis, Inc. (CDXS)'s New Drug Manufacturing Technology 7/15/2014
Harlan Laboratories, Inc. And Fluofarma Sign Strategic Collaboration Agreement 7/15/2014
Theorem Clinical Research And Excel Life Sciences Form Strategic Relationship 7/15/2014
Iroko Pharmaceuticals Announces New Strategic Agreement To Commercialize ZORVOLEX® In Brazil 7/15/2014
LEO Pharma & Klox Technologies Strike Global Dermatology Deal 7/15/2014
Absorption Systems Announces License Agreement With Pfizer Inc. (PFE) 7/15/2014
Hovione And Merrion Pharmaceuticals, Inc. Announce Strategic Partnership On Use Of Merrion's GIPET Technology 7/15/2014
Geisinger Health System And Indivumed Inc. Partner For Personalized Medicine Initiative 7/15/2014
EU Nations Join Forces Against Gilead Sciences, Inc. (GILD)'s "Exorbitant" Hepatitis C Drug 7/14/2014
Genmab A/S (GEN.CO) To Receive Milestone Payment In Duobody Platform Collaboration With Janssen Biotech Inc. (JNJ) 7/14/2014
Pareto Biotechnologies Announces Technology Partnership With DNA 2.0, Inc. 7/14/2014
Hemispherx Biopharma (HEB) And Bioclones, A Leading South African Biotechnology Company, Join Forces On Novel Therapeutic Cancer Vaccine 7/14/2014
Ventana Medical Systems, Inc. (VMSI) And Merck KGaA (MKGAF.PK), Darmstadt, Germany To Develop Companion Diagnostic Test For Cancer Treatment 7/11/2014
Ipsen (IPN.PA) And Galderma Laboratories Become Exclusive Partners For Development And Marketing Of Neurotoxins In The US, Canada, Brazil And Europe 7/11/2014
Abbott Laboratories (ABT) Builds Long-Term Commitment In China 7/11/2014
NicOx SA (COX.PA) Focuses U S. Operations On National Launches Of Sjo™ And Retnagene™ And Restructures RPS® Licensing Agreement 7/10/2014
Tekmira Pharmaceuticals Corporation (TKMR) Receives $1.5 Million Milestone Payment 7/10/2014
HD Biosciences Co., Ltd And Marshall University School of Medicine Reach Drug Discovery Co-Development Agreement 7/10/2014
Uppsala University Hospital And Elekta To Further Cancer Research In Sweden 7/10/2014
Collaboration Between Glatt And Innopharma Labs For Real-Time In-Line Particle Characterisation In Batch / Continuous Production 7/10/2014
Taconic and CERBM-IGBMC Collaborate To Offer Cre-ERT Technology For Inducible Gene Targeting In Genetically Modified Rodents 7/10/2014
Lightlake Therapeutics Inc. (LLTP) Signs Agreement With Commercial Contract Manufacturer For Its Opioid Overdose Reversal Treatment 7/9/2014
AstraZeneca PLC (AZN), Max Planck Institute To Create Satellite Chemistry Unit 7/9/2014
Protea Biosciences, Inc. Announces Alzheimer's Research Collaboration With University of Southampton, U.K. 7/9/2014
Advaxis, Inc. Selects Inventiv Health Clinical To Conduct Clinical Trials Of Immunotherapy Candidates 7/9/2014
uniQure And Medison Pharma Ltd. Sign Glybera® Distribution Agreement For Israel 7/9/2014
Protea Biosciences, Inc. And Insphero AG Enter Into Collaboration And Co-Marketing Agreement To Combine 3D Technologies 7/9/2014
Lexicon Pharmaceuticals, Inc. (LXRX) And Juvenile Diabetes Research Foundation Collaborate For Phase 2 Clinical Trial Of LX4211 In Type 1 Diabetes 7/9/2014
Servomex And H2scan Partnership Challenges Traditional Sensing With Innovative Technologies For HP Processes 7/9/2014
Open Medicine Institute Collaborates With VMware And Others - Addario Lung Cancer Trials Use New OpenMedNet Platform 7/9/2014
Evotec AG (EVTG.F) To Collaborate With Fraunhofer In Joint Drug Discovery Programmes 7/8/2014
Technical Resources International, Inc. And Nuventra Pharma Sciences To Provide Pharmacokinetic And Pharmacodynamic Services To The National Institute on Drug Abuse (NIDA) 7/8/2014
PHT Corporation Selects Google Inc. Nexus Android Smartphone For Logpad® System Use In Clinical Research Programs 7/8/2014
Vivione Biosciences Signs Strategic Alliance Agreement With IEH And Launches New Oil And Gas Product Offerings 7/8/2014
New Immunogenicity Analysis Tool Emerges From Dartmouth College-EpiVax, Inc.-University of Rhode Island Collaboration "In Silico" Host Cell Protein For Protein Therapeutics 7/8/2014
Hemispherx Biopharma (HEB) And Bioclones Join Forces In Effort To Eradicate HIV/AIDS Virus Based On Recent Clinical Insights Of Wistar Institute, University of Pennsylvania 7/8/2014
International Stem Cell Corporation Signs Agreement Including Certain Terms For A Definitive License Agreement With ROHTO Pharmaceutical Co., Ltd. Of Japan 7/8/2014
Incyte Corporation (INCY) Grabs $25 Million Milestone From Novartis AG (NVS) 7/8/2014
Histogen Oncology Created To Develop Novel Biologic Cancer Treatments 7/8/2014
Mariel Therapeutics Announces Definitive Agreement To Acquire Stryker Corporation  (SYK)'s BMP-7 Assets For Potential Use In Osteoarthritis And Organ Fibrosis 7/8/2014
National Center for Genome Resources And Simbiot Inc. Announce Global, Strategic Partnership 7/8/2014
NextCODE, University College Dublin's Acord Take Aim At Genetic Causes Of Autism And Rare Diseases 7/7/2014
Orgenesis Signs Agreement With MaSTherCell To Scale Manufacturing Of Insulin-Producing Liver Cells To Combat Diabetes 7/7/2014
BioInvent (BOVNF) Has Received Milestones From Bayer Pharma S.A. (TEVA) And Servier 7/7/2014
Portola Pharmaceuticals, Inc. Enters Into Clinical Collaboration Agreement With Daiichi Sankyo, Inc. (4568.t) For Phase 3 Studies Of Factor Xa Inhibitor Antidote, Andexanet Alfa, And Edoxaban 7/7/2014
Genmab A/S (GEN.CO) Reaches USD 25 Million Milestone In Daratumumab Collaboration With Janssen Biotech Inc. (JNJ) 7/7/2014
Compugen Ltd. (CGEN) Discloses Achievement Of Milestone In Cancer Immunotherapy Collaboration With Bayer HealthCare (BAY) 7/7/2014
Yabao Pharmaceuticals Enters Innovative Partnership With Eli Lilly and Company (LLY) To Develop Diabetes Treatment 7/7/2014
Cytori Therapeutics, Inc. (CYTX) Receives Notice Of Intent To Exercise First Contract Option From Biomedical Advanced Research and Development Authority (BARDA) 7/7/2014
Cliniworks Forms A Strategic Alliance With Pfizer Inc. (PFE) To Develop A Population Health Management Platform With Advanced Analytics And Patient Care Capabilities 7/7/2014
Sanofi (France) (SAN.PA) Raises Stake In Regeneron Pharmaceuticals, Inc. (REGN) 7/3/2014
CMC Biologics Enters Into Commercial Supply Agreement With Portola Pharmaceuticals, Inc. For Manufacturing Of First-In-Class Factor Xa Inhibitor Antidote Andexanet Alfa 7/3/2014
UCB Group (UCBJF.PK) And Dermira Enter Into Strategic Collaboration In Dermatology To Broaden Patient Access To Cimzia® (Certolizumab Pegol) 7/3/2014
MRC Technology And AstraZeneca PLC (AZN) Renew Collaboration To Identify Novel Targets For Discovery Research 7/3/2014
FINOX Biotech And Save The Children Switzerland Announce 0.12CHF (€0.10) Will Be Donated For Every Bemfola® Product Leaving The Swiss Factory. 7/3/2014
Recipharm AB And Pharmanest Form Collaboration For Commercial Manufacture And Supply Of SHACT 7/3/2014
BRAIN AG In Partnership With AnalytiCon Discovery GmbH 7/3/2014
BIND Therapeutics (BIND) Ends Cancer Drug Pact With Amgen (AMGN); BIND Stock Down -10.02% At Market Close (July 3, 2014) 7/3/2014
Fosun Pharma Terminates $531 Million Out-licensing Deal With Sellas 7/2/2014
genOway Offers Industry Scientists Immediate Access To EUCOMM Conditional KO Mouse Models 7/2/2014
AIMM Therapeutics’ Partner MedImmune (AZN) Starts Clinical Studies With RSV Antibody 7/2/2014
Isis Pharmaceuticals, Inc. (ISIS) Earns $1 Million From GlaxoSmithKline (GSK) For Advancing Hepatitis B Virus Program 7/2/2014
c-LEcta And Purolite Collaborate To Market Calb Immo Plus™ Immobilized Enzyme 7/1/2014
Biohit And Giraffes Pharmaceuticals Co. To Sign An Acetium Distribution Agreement 7/1/2014
First Licensing Deals For Stem Cell Company Accellta 7/1/2014
Eurofins Genomics And AmpTec Close Distribution Agreement For Very Long Synthetic RNAs 7/1/2014
Case Western Reserve University, University Hospitals Announce Collaborative Fundraising Initiative For Adolescent And Young Adult Cancer 7/1/2014
Cortex Pharmaceuticals, Inc. (COR) Enters Into New License Agreement With The University of Illinois Granting Cortex Patent Rights To The Use Of Cannabinoids For The Treatment Of Sleep Related Breathing Disorders 7/1/2014
CompaniondDx Reference Lab, LLC And Regenwell Holdings, LLC Partner To Provide World-Class Care To Patients 7/1/2014
Boston Strategics Corporation Announces Licensing Deal With Eisai Company, Ltd. (ESALY.PK) 7/1/2014
University of Maryland, GBSI Partner To Advance Antibody Standards 7/1/2014
CureVac GmbH, Sanofi (France) (SAN.PA) Strike €150.5 Million+ Vaccine Pact 7/1/2014
Brickell Biotech Announces Licensing Agreement For Its Novel Retinoid Therapy With Merz North America 6/30/2014
Vectura Group plc (VEC.L) Announces A Further US Collaboration Agreement With A Leading International Pharmaceutical Company For The VR506 Asthma Therapy 6/30/2014
Tiziana Life Sciences Plc Licensing Agreement To Develop Stem Cell Based Breast Cancer Diagnostic Building An Oncology Franchise 6/30/2014
FSC LaboratoriesTo Market Aciphex® Sprinkle™ (Rabeprazole Sodium) In The U.S. 6/30/2014
TrovaGene, Inc. Enters Into A Strategic Alliance With The Robert H. Lurie Comprehensive Cancer Center Of Northwestern University And The Northwestern Medicine Developmental Therapeutics Institute 6/30/2014
Biomnis, Genoma, And The Center For Human Genetics And Laboratory Diagnostics Martinsried, Enter Agreements With Illumina, Inc. (ILMN) To Expand Access For Non-Invasive Prenatal Testing Across Europe 6/30/2014
BrainStorm Cell Therapeutics Inc. And Octane Successfully Construct A Bioreactor Prototype For Industrial-Scale Manufacturing Or NurOwn Stem Cells 6/27/2014
IGI Laboratories, Inc. Announces Joint Stipulation 6/26/2014
Alzheimer's Drug Discovery Foundation And Ondeckbiotech Partner To Further Expand ADDF ACCESS Virtual Network 6/26/2014
Applied StemCell, Inc. Announces Licensing Agreement With Broad Institute For CRISPR/Cas9 Gene-Editing Technology. 6/26/2014
Teijin Limited Signs Exclusive Development And Sales Agreement For New SCID-ADA-deficiency Therapeutic Agent 6/26/2014
RayBiotech Executes Master Services Agreement With AmbioPharm, Inc. 6/26/2014
Liomont And Oncobiologics Inc. Partner To Launch Biosimilars In Mexico 6/26/2014
Roche (RHHBY) Invests In Stratos Genomics for Further Development Of The "Sequencing By Expansion" (SBX) Method Applied To Single Molecule Nanopore Sequencing 6/26/2014
Johnson & Johnson (JNJ), Dana-Farber Cancer Institute Launch $10 Million Lung Cancer Collaboration 6/25/2014
Cambridge-Based Mersana Therapeutics, Inc. Strikes New Oncology Pact Worth $792 Million With Merck KGaA (MKGAF.PK) 6/25/2014
Roche (RHHBY)'s Commercial Launch Of MabThera SC Triggers Milestone Payment To Halozyme Therapeutics, Inc. (HALO) 6/25/2014
Morphotek Inc. And Sorrento Therapeutics, Inc. Sign An Exclusive Research And Option Agreement To Generate And Develop Morphotek Antibody Drug Conjugates 6/25/2014
HedgePath Pharmaceuticals Secures Interim Financing To Commence Clinical Trials And Finalizes Key Agreement With Mayne Pharma Limited 6/25/2014
Immune Pharmaceuticals, Inc. Partners With Patient Community Group LYFEBULB 6/25/2014
TNI BioTech Signs Non-Exclusive Distribution Agreement For Lodonal™ For Cancer And Receives First Sale In Africa 6/25/2014
BioAlliance Pharma Release: Execution Of A License Agreement With EMS For Sitavig® In Brazil 6/25/2014
MYOS (MYOS) Establishes Research Relationship With Rutgers University In Muscle Science 6/25/2014
NextCODE Helps ANZAC Research Institute Bring Whole-Genome Sequencing Into Clinical Care 6/24/2014
Bristol-Myers Squibb Company (BMY) Ties It Up With Duke University In Bid To Focus On Clinical Trial Transparency 6/24/2014
InformedDNA Partners With Edimer Pharmaceuticals To Support XLHED Research 6/24/2014
Applied Genetic Technologies Corporation And SAFC Create Strategic Partnership To Provide Gene Therapy Manufacturing Services 6/24/2014
Vectura Group plc (VEC.L) Rlease: VR315 US Development Milestone 6/24/2014
TG Therapeutics, Inc. (MHA) Completes Global Licensing Agreement With Ligand Pharmaceuticals Inc. (LGND) For The Development Of Inhibitors Of IRAK4 6/24/2014
Zealand Pharma  (ZEAL.CO) Provides An Update On Activities Relating To Danegaptide For The Protection Of Cardiac Tissue Against Reperfusion Injuries 6/24/2014
Debiopharm Group And TCG Lifesciences Announce Successful Completion Of First Phase Of Research Collaboration On Discovery Of Novel Antibiotics 6/24/2014
Eurobiomed And BIOCOM Sign A Cooperation Agreement At The Biotechnology Industry Organization (BIO) International Convention In San Diego 6/24/2014
Cook Pharmica LLC And Selexis SA Establish Customized Biologic Drug Development And Manufacturing Services Platform 6/24/2014
SCORR Marketing And BioInformatics LLC Announce Strategic Partnership 6/24/2014
ClinicalRM (formerly known as Clinical Research Management) And Ohio Clinical Trials Collaborative Launch Partnership 6/24/2014
Isis Pharmaceuticals, Inc. (ISIS) Earns $1 Million From GlaxoSmithKline (GSK) For Advancing ISIS-TTR Rx 6/24/2014
Ferring Pharmaceuticals, Roche (RHHBY) Partner Up To Make Personalised Infertility Treatment Possible 6/24/2014
Aurigene Discovery Technologies Limited And Orion Corporation Announce Research, Collaboration And Option Agreement For Rights To Aurigene's Epigenetics Program For Pan BET And Selective BET Bromodomain Inhibitors 6/24/2014
Bionomics Limited (BNO.AX) Clinches Alzheimer's Research And Funding Deal With Merck & Co., Inc. (MRK) Worth Up To $526 Million 6/24/2014
Sanofi (France) (SAN.PA) Throws Cancer Drug Back To Merrimack Pharmaceuticals Inc. (MACK) 6/23/2014
Drug Giant Bayer HealthCare (BAY), Dimension Therapeutics Seal A Pact Worth $252 Million 6/23/2014
Alexion Pharmaceuticals Inc. (ALXN) And Cincinnati Children's Hospital Medical Center's Launch Rare Disease Innovation Fund 6/23/2014
Eli Lilly and Company (LLY) Collaborates With Public And Private Healthcare Organizations To Provide Medical Students An Opportunity To Explore Healthcare Outside The Traditional Learning Environment 6/23/2014
Servier And miRagen Therapeutics Extend Collaboration For The Research, Development And Commercialization Of Microrna-Targeting Drugs For Cardiovascular Disease 6/23/2014
Pieris Achieves Milestone Payment In Daiichi Sankyo, Inc. (4568.t) Collaboration To Develop Anticalin® Therapeutics 6/23/2014
BioLineRx Ltd. In-Licenses Novel Compound For Treatment Of Neuropathic Pain 6/23/2014
China Biologic Products Announces Favorable Reduction In Value Added Tax Rate 6/23/2014
T23 Announces Global License Of The Scripps Research Institute' CD22 Siglec Oncoimmunological Platform For B-Cell Tumors 6/23/2014
PeptiMed Signs Agreement With National Cancer Institute to Assess Safety of HelpTM Drug Delivery Nanoparticle Formulations 6/23/2014
ProBioGen AG Signs GlymaxX ADCC Enhancement Technology License Deal 6/23/2014
IGI Laboratories, Inc. Completes Its Seventh Anda Filing For 2014 Under Joint Drug Development And Commercialization Agreement With IMPAX Laboratories, Inc. (IPXL), Inc. 6/20/2014
Teijin Pharma To Develop Sheet-Type Fibrin Sealant For Surgical Operations 6/20/2014
Major Drugmakers Like AstraZeneca PLC (AZN), GlaxoSmithKline (GSK). And Johnson & Johnson (JNJ) Link Up With Academia In Huge $27 Million UK Dementia Project 6/20/2014
IsoRay, Inc. (ISR) Announces New Russian And Peruvian International Distributor Agreements For The Sale Of IsoRay's Full Line Of Products 6/20/2014
Vivione Biosciences Announces Agreement With Litmus, LLC For Molecular Design Rights 6/20/2014
Avoca Signs Supply Agreement With Synthetic Genomics, Inc. To Become Domestic Source Of Natural Astaxanthin 6/20/2014
Johnson & Johnson (JNJ) Shows Off Deals With Six Boston Biotech Firms— Padlock Therapeutics, Energesis Pharmaceuticals, Navitor Pharmaceuticals, Ascelegen Therapeutics, Minerva Neurosciences, Inc. (NERV), And Rodin Therapeutics 6/20/2014
Endocyte, Inc. (ECYT) Plummets After Merck & Co., Inc. (MRK) Backs Out Of Drug Development Deal; Stock Down -13.99% At Market Close (June 18, 2014) 6/19/2014
French Biotech Cellectis (ALCLS) Surges As Pfizer Inc. (PFE) Signs Cancer Immunotherapy Pact Worth $265 Million 6/19/2014
Pacific Biosciences (PACB) And GenDx Initiate Co-Marketing Activities For Full-Length HLA Gene Sequencing Products 6/19/2014
BIND Therapeutics, Roche (RHHBY) Team Up On Discovery Of Novel Nanomedicines 6/19/2014
ChromaDex, Inc. Signs Collaboration Research Agreement With St. Jude Children's Research Hospital 6/19/2014
Cepheid (CPHD) And Leading Pharmaceutical Companies Partner On A Diagnostic Test To Help Tackle Multidrug-Resistant Bacterial Infections 6/19/2014
NicOx SA (COX.PA) And Sequenom Inc. (SQNM) Announce The Launch Of Expanded Access To Retnagene™ Test Portfolio In The U.S. 6/19/2014
Evotec AG (EVTG.F) Receives Milestone Payment As Part Of Its Discovery Alliance With Boehringer Ingelheim Corporation 6/19/2014
Tomtom Co-Founder Navigates Into Biotech With Investment In Ocello 6/19/2014
PsiOxus Therapeutics Limited Select BioOutsource To Support Clinical Sample Analysis For OCTAVE Ovarian Cancer Study 6/19/2014
Quintiles, Inc. (Q) And Modern Marketing Concepts Collaborate To Launch Innovative Marketing Analytics Platform 6/19/2014
CEA-Leti Joins 14 Partners In Horizon 2020 Project Targeting Antibiotic-Resistant Bacteria 6/19/2014
Alnylam Pharmaceuticals (ALNY) And The Alpha-1 Project (TAP) Form Collaboration For Advancement Of ALN-AAT, An Rnai Therapeutic In Development For The Treatment Of Alpha-1 Antitrypsin (AAT) Deficiency-Associated Liver Disease 6/19/2014
Vernalis PLC (VNLPY.PK) And Servier Achieve Research Milestone As BCL-2 Inhibitor Drug Candidate Enters Phase I 6/19/2014
Courtagen Life Sciences Announces Partnership With Seizure Tracker To Better Understand Relationships Between Genetics, Seizure Activity And Anti-epileptic Treatments 6/19/2014
SteadyMed Announces Development And Manufacturing Agreement With Bespak, Ltd. 6/19/2014